The global anti-acne cosmetics market size was valued at USD 2.3 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.1% from 2021 to 2028. The negative social stigma associated with acne and the rising usage of cosmetics by both men and women, especially from the emerging economies, are the key factors driving the market growth. Acne is the most common skin disorder among adolescents. According to an article published by the Journal of The European Academy of Dermatology and Venereology, more than 95% of boys and nearly 85% of girls are affected by acne. Out of these, nearly 40% experience moderate‐to‐severe acne and nearly 50% continue to have acne in their adulthood. Thus, the high prevalence of this skin disorder is anticipated to fuel market growth.
Acne patients are at a high risk of suffering from anxiety, depression, low self-esteem, poor quality of life, and loneliness. This can be attributed to the emotional and mental associations that an individual has with his/her appearance. These psychological effects are also indirectly fueled by the increasing usage of social media and photo-editing apps.
Furthermore, growing internet penetration, an increasing number of e-commerce platforms selling these products, and increasing urbanization are estimated to improve the awareness among the target population, especially in developing economies. All these factors are projected to support the market growth.
Despite the Covid-19 pandemic negatively impacting several industries, the skincare products manufacturers have witnessed an increased sales. Australian skincare brand, Real-u Skincare, witnessed a boost in its overall sales during the pandemic.
The creams & lotions segment accounted for the maximum revenue share of over 40% in 2020 owing to the high demand for these products as they provide protection from bacteria and skin infliction, such as psoriasis and eczema. On the basis of product, the market is divided into masks, creams & lotions, cleansers & toners, and others. The other segment is projected to register the fastest CAGR from 2021 to 2028. This segment includes products, such as face wash, gels, serums, and essential oils. High demand for these products due to their compatibility with various skin types is driving the segment growth.
The women end-use segment dominated the market in 2020 and accounted for the largest share of more than 50% of the global revenue share. On the basis of end-use, the market has been bifurcated into women and women end-users. The women end-use segment is further expected to register the fastest CAGR from 2021 to 2028. This growth can be attributed to the high prevalence of skin disorder among the female population.
Acne is highly prevalent in women than men due to hormonal changes, such as during the menstrual cycle. According to a survey, 62.2% of pre-menopausal women reported worsening of acne during the menstrual cycle. The men end-use segment held a substantial market share in 2020. The growing prevalence of acne in men is propelling the demand for these products.
Asia Pacific dominated the global anti-acne cosmetics market in 2020 accounting for a share of over 39%. The regional market is also estimated to register the fastest CAGR over the forecast period. Asia Pacific is the largest potential export market for U.S.-based products owing to a high target population. Economies, such as Australia, Japan, and South Korea, are some of the largest consumers of well-established U.S.-based brands.
In addition, Vietnam, Malaysia, and Indonesia are few other regions expected to witness high product demand in the forecast period. China is one of the most promising cosmetics markets in the Asia Pacific region due to the demand for products of high-end foreign brands, as nearly 80% of the country’s cosmetics market is dominated by western brands.
Mergers & acquisitions are one of the key sustainable strategies undertaken by market players to expand their geographical reach. For instance, L'Oréal is planning to expand its business in India and enhance its skin and make-up portfolio to meet the country’s increasing demand for cosmetic products. Some of the key players profiled in the global anti-acne cosmetics market include:
Neutrogena
Clinique
Murad
Kose
LaRochPosay
Mentholatum
L'Oréal
Proactiv
Vichy
Report Attribute |
Details |
Market size value in 2021 |
USD 2.5 billion |
Revenue forecast in 2028 |
USD 4.7 billion |
Growth rate |
CAGR of 9.1% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; China; Japan; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Neutrogena; Clinique; Murad; Kose; LaRochPosay; Mentholatum; L'Oréal; Proactiv; Vichy |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global anti-acne cosmetics market report on the basis of product type, end-use, and region:
Product Type Outlook (Revenue, USD Million, 2016 - 2028)
Mask
Creams & Lotions
Cleansers & Toners
Others
End-use Outlook (Revenue, USD Million, 2016 - 2028)
Women
Men
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
Japan
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global anti-acne cosmetics market size was estimated at USD 2.37 billion in 2020 and is expected to reach USD 2.5 billion in 2021.
b. The global anti-acne cosmetics market is expected to grow at a compound annual growth rate of 9.1% from 2021 to 2028 to reach USD 4.71 billion by 2028.
b. Asia Pacific dominated the anti-acne cosmetics market with a share of 39.95% in 2020. This is attributable to economies, such as Australia, Japan, and South Korea which are some of the largest consumers for well-established U.S. based products.
b. Some key players operating in the anti-acne cosmetics market include Neutrogena, Clinique, Murad, Kose, LaRochPosay, Mentholatum, L'Oréal, Proactiv, and Vichy.
b. Key factors that are driving the anti-acne cosmetics market growth include the negative social stigma associated with acne and rising consumption of cosmetics by both men and women, especially from the emerging economies.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.